Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cheng Jiang
Institutions:
Jiangxi University of Traditional Chinese Medicine,
Zhejiang Chinese Medical University,
Tongde Hospital of Zhejiang Province
Observed institutions:
Jiangxi University of Traditional Chinese Medicine,
Zhejiang Chinese Medical University,
Tongde Hospital of Zhejiang Province,
Hangzhou Medical College,
Huazhong University of Science and Technology
ORCID:
0000-0001-8454-749X
Observed ORCID:
0000-0001-8454-749X
OpenAlex ID:
A5001208053
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
2024
·
Jia-Ling Hu
, Jing-Ying Wu
, et al.
·
The Journal of Headache and Pain
·
22
PDF
Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post‐marketing safety
2024
·
Cheng Jiang
, Jiancheng Qian
, et al.
·
Pharmacology Research & Perspectives
·
22
PDF
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
2024
·
Yiming Qi
, Jing Li
, et al.
·
Scientific Reports
·
18
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
2024
·
Jiancheng Qian
, Shuohan Zhang
, et al.
·
BMC Cancer
·
15
PDF
Safety profile of lasmiditan: a retrospective post-marketing pharmacovigilance study based on the real-world data of FAERS database
2024
·
Xiaochen Wan
, Shuohan Zhang
, et al.
·
Expert Opinion on Drug Safety
·
12
A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime
2024
·
Cheng Jiang
, Xiaoxiao Zheng
, et al.
·
Therapeutic Advances in Drug Safety
·
11
Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system
2025
·
Cheng Jiang
, Jiancheng Qian
, et al.
·
BMC Pharmacology and Toxicology
·
6
PDF
Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA Adverse Event Reporting System database
2024
·
Shuangshuang Wu
, Yiming Qi
, et al.
·
Expert Opinion on Drug Safety
·
3
Phosphoenolpyruvate carboxykinase 2 is a promising prognostic biomarker that correlates with peritumoral dendritic cell infiltration in glioblastoma
2024
·
Li Yi
, Cheng Jiang
, et al.
·
Journal of Cancer
·
3
Integrated Flavoromics and Metabolomics Reveal Aroma and Bioactive Characteristics of Six Mainstream Citri Reticulatae Pericarpium Cultivars
2026
·
Luxin Xie
, Yanjing Dong
, et al.
·
Foods
·
2
Exploration of adverse event profiles for glofitamab: A disproportionality analysis using the FDA adverse event reporting system
2025
·
Meng Zhou
, Cheng Jiang
, et al.
·
PLoS ONE
·
1
PDF
Adverse events associated with cefuroxime ocular administration: potential demographic and dose-dependent heterogeneity assessment
2026
·
Fangqiong Li
, Jinyu Luo
, et al.
·
Cutaneous and Ocular Toxicology
N6 ‐Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia–Reperfusion Injury by Suppressing AQP4 Expression
2026
·
Wei Chen
, Luyuan Cao
, et al.
·
CNS Neuroscience & Therapeutics
PDF
Comprehensive analysis of cefuroxime-associated adverse events: Insights from JADER database (2004–2024) and comparison with FAERS database
2026
·
Fangqiong Li
, Jinyu Luo
, et al.
·
Medicine
Show more works
View as search
Works count:
14
Citation count:
115
H-index:
6
I10-index:
6
Year
Topic
Type